Summary:
Florida Premier Research Institute is conducting a 54 week study to evaluate the efficacy and treatment of a research drug to treat nephropathy in CKD (chronic kidney disease). It is a sub-cutaneous injection that is administered every biweekly between weeks 2 and 48.
Qualified Participants Must:
• Have history of Diabetes Mellitus with nephropathy
• Have type 1 diabetes and be between 21 to 80 years of age or have type 2 diabetes and be between 30 to 80 years of age
• Not be pregnant during the study
Qualified Participants May Receive:
Compensation, study drug, and able to speak with our nephrologist.